These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36580423)

  • 1. Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer.
    Michael P; Roversi G; Brown K; Sharifi N
    Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36580423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMX controls 3βHSD1 and sex steroid biosynthesis in cancer.
    Li X; Berk M; Goins C; Alyamani M; Chung YM; Wang C; Patel M; Rathi N; Zhu Z; Willard B; Stauffer S; Klein E; Sharifi N
    J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36647826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to assessing 3β-hydroxysteroid dehydrogenase-1.
    Alyamani M; McManus J; Patel M; Sharifi N
    Methods Enzymol; 2023; 689():89-119. PubMed ID: 37802584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracrinology-revisited and prostate cancer.
    Penning TM; Detlefsen AJ
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105499. PubMed ID: 31614208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is dehydroepiandrosterone a hormone?
    Labrie F; Luu-The V; Bélanger A; Lin SX; Simard J; Pelletier G; Labrie C
    J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.
    Sikora MJ; Cordero KE; Larios JM; Johnson MD; Lippman ME; Rae JM
    Breast Cancer Res Treat; 2009 May; 115(2):289-96. PubMed ID: 18521740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment?
    Piao YS; Wiesenfeld P; Sprando R; Arnold JT
    J Steroid Biochem Mol Biol; 2013 Nov; 138():206-13. PubMed ID: 23770322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
    du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
    J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroid hormone metabolism and prostate cancer.
    Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer.
    Klein H; Bressel M; Kastendieck H; Voigt KD
    Am J Clin Oncol; 1988; 11 Suppl 2():S30-6. PubMed ID: 2853935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens and mechanisms of prostate cancer progression.
    Carruba G
    Ann N Y Acad Sci; 2006 Nov; 1089():201-17. PubMed ID: 17261768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
    Negri-Cesi P; Colciago A; Poletti A; Motta M
    Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer.
    Sharifi N
    J Investig Med; 2012 Feb; 60(2):504-7. PubMed ID: 22064602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration.
    Wu Y; Tang L; Azabdaftari G; Pop E; Smith GJ
    Mol Cell Endocrinol; 2019 Apr; 486():79-88. PubMed ID: 30807787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New agents and strategies for the hormonal treatment of castration-resistant prostate cancer.
    Sharifi N
    Expert Opin Investig Drugs; 2010 Jul; 19(7):837-46. PubMed ID: 20524793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
    Gingras S; Moriggl R; Groner B; Simard J
    Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
    Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
    Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.